Tuesday, April 12, 2022 3:51:27 PM
GP41
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
5T P01Act AI138211Project 04Year
ALAM, S. MUNIR Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2022 NIAID
NIAID
$1,469,556
View Similar Projects
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
5T U19Act AI142636Project 04Year 6243
RUPRECHT, RUTH MARGRIT Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2021 NIAID
$507,591
View Similar Projects
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
5T U19Act AI142636Project 04Year
RUPRECHT, RUTH MARGRIT Principal Investigator(s)/ Project Leader(s)
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2021 NIAID
NIAID
$1,719,534
View Similar Projects
Structures and lipid interactions of curvature-inducing membrane peptides by NMR
5T R01Act GM066976Project 17Year
HONG, MEI Principal Investigator(s)/ Project Leader(s)
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2021 NIGMS
NIGMS
$337,339
View Similar Projects
Vaccine development and production
5T U19Act AI142636Project 04Year 6242
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2021 NIAID
$1,077,795
View Similar Projects
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
5T DP1Act DA043893Project 05Year
KIM, PETER S Principal Investigator(s)/ Project Leader(s)
STANFORD UNIVERSITY 2021 NIDA
NIDA
$785,000
View Similar Projects
Design and validation of VLP/mRNA-based vaccine strategies against SARS-CoV2
1T ZIAAct AI001314Project 02Year
LUSSO, PAOLO Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 2021 NIAID
NIAID
$121,121
View Similar Projects
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
5T P01Act AI138211Project 03Year
ALAM, S. MUNIR Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2021 NIAID
NIAID
$1,552,366
View Similar Projects
Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
1T ZIAAct AR041116Project 26Year
WINGFIELD, PAUL T Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES 2021 NIAMS
NIAMS
$136,545
View Similar Projects
Structural study of the HIV1 gp41 coat protein
1T ZIAAct DK075023Project 13Year
BAX, ADRIAAN Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES 2021 NIDDK
NIDDK
$658,712
View Similar Projects
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
5T U19Act AI142636Project 03Year 6243
RUPRECHT, RUTH MARGRIT Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2020 NIAID
$655,586
View Similar Projects
Structures and lipid interactions of curvature-inducing membrane peptides by NMR
5T R01Act GM066976Project 16Year
HONG, MEI Principal Investigator(s)/ Project Leader(s)
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2020 NIGMS
NIGMS
$337,339
View Similar Projects
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
5T U19Act AI142636Project 03Year
RUPRECHT, RUTH MARGRIT Principal Investigator(s)/ Project Leader(s)
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2020 NIAID
NIAID
$1,855,534
View Similar Projects
Vaccine development and production
5T U19Act AI142636Project 03Year 6242
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2020 NIAID
$938,754
View Similar Projects
Design and validation of VLP/mRNA-based vaccine strategies against SARS-CoV2
1T ZIAAct AI001314Project 01Year
LUSSO, PAOLO Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 2020 NIAID
NIAID
$67,461
View Similar Projects
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
5T DP1Act DA043893Project 04Year
KIM, PETER S Principal Investigator(s)/ Project Leader(s)
STANFORD UNIVERSITY 2020 NIDA
NIDA
$785,000
View Similar Projects
Covalent capture of small molecule - gp41 complexes
5T R21Act AI140904Project 02Year
GOCHIN, MIRIAM Principal Investigator(s)/ Project Leader(s)
TOURO UNIVERSITY OF CALIFORNIA 2020 NIAID
NIAID
$178,750
View Similar Projects
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
5T P01Act AI138211Project 02Year
ALAM, S. MUNIR Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2020 NIAID
NIAID
$2,138,470
View Similar Projects
Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
1T ZIAAct AR041116Project 25Year
WINGFIELD, PAUL T Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES 2020 NIAMS
NIAMS
$857,575
View Similar Projects
Structural study of the HIV1 gp41 coat protein
1T ZIAAct DK075023Project 12Year
BAX, ADRIAAN Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES 2020 NIDDK
NIDDK
$995,227
View Similar Projects
The role of non-broadly neutralizing antibodies targeting gp41 structural epitopes in long term nonprogression of HIV infection
5T R01Act AI125119Project 05Year
HICAR, MARK DANIEL Principal Investigator(s)/ Project Leader(s)
STATE UNIVERSITY OF NEW YORK AT BUFFALO 2020 NIAID
NIAID
$390,782
View Similar Projects
Deep Topological Sampling of Protein Structures
5T R01Act GM118543Project 04Year
DONALD, BRUCE R. Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2020 NIGMS
NIGMS
$306,511
View Similar Projects
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
1T U19Act AI142636Project 01Year 6243
RUPRECHT, RUTH MARGRIT Principal Investigator(s)/ Project Leader(s)
TEXAS BIOMEDICAL RESEARCH INSTITUTE 2019 NIAID
$369,510
View Similar Projects
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
1T U19Act AI142636Project 01Year
EDWARDS, DONALD BRUCE Principal Investigator(s)/ Project Leader(s)
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
TEXAS BIOMEDICAL RESEARCH INSTITUTE 2019 NIAID
NIAID
$1,213,216
View Similar Projects
Structures and lipid interactions of curvature-inducing membrane peptides by NMR
5T R01Act GM066976Project 15Year
HONG, MEI Principal Investigator(s)/ Project Leader(s)
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2019 NIGMS
NIGMS
$337,339
View Similar Projects
Vaccine development and production
1T U19Act AI142636Project 01Year 6242
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
TEXAS BIOMEDICAL RESEARCH INSTITUTE 2019 NIAID
$777,557
View Similar Projects
Crystallography and NMR-guided generation of fungal calcineurin inhibitors
5T P01Act AI104533Project 05Year 6760
HEITMAN, JOSEPH Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2019 NIAID
$269,623
View Similar Projects
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
5T DP1Act DA043893Project 03Year
KIM, PETER S Principal Investigator(s)/ Project Leader(s)
STANFORD UNIVERSITY 2019 NIDA
NIDA
$785,000
View Similar Projects
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
7T U19Act AI142636Project 02Year
RUPRECHT, RUTH MARGRIT Principal Investigator(s)/ Project Leader(s)
FLEURY, SYLVAIN Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF LOUISIANA AT LAFAYETTE 2019 NIAID
NIAID
$727,169
View Similar Projects
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
1T P01Act AI138211Project 01A1Year
ALAM, S. MUNIR Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2019 NIAID
NIAID
$1,247,121
View Similar Projects
Covalent capture of small molecule - gp41 complexes
1T R21Act AI140904Project 01A1Year
GOCHIN, MIRIAM Principal Investigator(s)/ Project Leader(s)
TOURO UNIVERSITY OF CALIFORNIA 2019 NIAID
NIAID
$214,500
View Similar Projects
Structural study of the HIV1 gp41 coat protein
1T ZIAAct DK075023Project 11Year
BAX, ADRIAAN Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES 2019 NIDDK
NIDDK
$995,227
View Similar Projects
Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
1T ZIAAct AR041116Project 24Year
WINGFIELD, PAUL T Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES 2019 NIAMS
NIAMS
$499,063
View Similar Projects
Deep Topological Sampling of Protein Structures
5T R01Act GM118543Project 03Year
DONALD, BRUCE R. Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2019 NIGMS
NIGMS
$306,720
View Similar Projects
The role of non-broadly neutralizing antibodies targeting gp41 structural epitopes in long term nonprogression of HIV infection
5T R01Act AI125119Project 04Year
HICAR, MARK DANIEL Principal Investigator(s)/ Project Leader(s)
STATE UNIVERSITY OF NEW YORK AT BUFFALO 2019 NIAID
NIAID
$391,089
View Similar Projects
Deep Topological Sampling of Protein Structures
3T R01Act GM118543Project 03S1Year
DONALD, BRUCE R. Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2019 NIGMS
NIGMS
$170,613
View Similar Projects
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design
5T R01Act AI114401Project 05Year
ZWICK, MICHAEL B Principal Investigator(s)/ Project Leader(s)
SCRIPPS RESEARCH INSTITUTE, THE 2018 NIAID
NIAID
$574,022
View Similar Projects
Glycan dependent epitopes of HIV broadly neutralizing antibodies
5T R01Act AI113867Project 05Year
PAULSON, JAMES C Principal Investigator(s)/ Project Leader(s)
SCHIEF, WILLIAM R. Principal Investigator(s)/ Project Leader(s)
SCRIPPS RESEARCH INSTITUTE, THE 2018 NIAID
NIAID
$962,498
View Similar Projects
Molecular Characterization of NKp44 Ligand on Astrocytes
5T R03Act NS101481Project 02Year
MATHEW, PORUNELLOOR ABRAHAM Principal Investigator(s)/ Project Leader(s)
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR 2018 NINDS
NINDS
$73,000
View Similar Projects
Development of anti-gp41 HIV-1 antibodies for penetration of blood brain barrier
5T R21Act NS098956Project 02Year
GORNY, MIROSLAW K Principal Investigator(s)/ Project Leader(s)
NEW YORK UNIVERSITY SCHOOL OF MEDICINE 2018 NINDS
NINDS
$188,187
View Similar Projects
Structures and lipid interactions of curvature-inducing membrane peptides by NMR
2T R01Act GM066976Project 14A1Year
HONG, MEI Principal Investigator(s)/ Project Leader(s)
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2018 NIGMS
NIGMS
$337,339
View Similar Projects
Crystallography and NMR-guided generation of fungal calcineurin inhibitors
5T P01Act AI104533Project 04Year 6760
HEITMAN, JOSEPH Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2018 NIAID
$298,465
View Similar Projects
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
5T DP1Act DA043893Project 02Year
KIM, PETER S Principal Investigator(s)/ Project Leader(s)
STANFORD UNIVERSITY 2018 NIDA
NIDA
$785,000
View Similar Projects
Structural study of the HIV1 gp41 coat protein
1T ZIAAct DK075023Project 10Year
BAX, ADRIAAN Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES 2018 NIDDK
NIDDK
$995,227
View Similar Projects
Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
1T ZIAAct AR041116Project 23Year
WINGFIELD, PAUL T Principal Investigator(s)/ Project Leader(s)
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES 2018 NIAMS
NIAMS
$554,290
View Similar Projects
Deep Topological Sampling of Protein Structures
5T R01Act GM118543Project 02Year
DONALD, BRUCE R. Principal Investigator(s)/ Project Leader(s)
DUKE UNIVERSITY 2018 NIGMS
NIGMS
$306,928
View Similar Projects
The role of non-broadly neutralizing antibodies targeting gp41 structural epitopes in long term nonprogression of HIV infection
5T R01Act AI125119Project 03Year
HICAR, MARK DANIEL Principal Investigator(s)/ Project Leader(s)
STATE UNIVERSITY OF NEW YORK AT BUFFALO 2018 NIAID
NIAID
$391,389
View Similar Projects
A His-tag Binding Membrane System for Generating Neutralizing Gp41 MPER antibodies
5T R21Act AI122964Project 02Year
LOVELL, JONATHAN F Principal Investigator(s)/ Project Leader(s)
STATE UNIVERSITY OF NEW YORK AT BUFFALO 2017 NIAID
NIAID
$238,115
View Similar Projects
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design
5T R01Act AI114401Project 04Year
ZWICK, MICHAEL B Principal Investigator(s)/ Project Leader(s)
SCRIPPS RESEARCH INSTITUTE, THE 2017 NIAID
NIAID
$574,022
View Similar Projects
Glycan dependent epitopes of HIV broadly neutralizing antibodies
5T R01Act AI113867Project 04Year
PAULSON, JAMES C Principal Investigator(s)/ Project Leader(s)
SCHIEF, WILLIAM R. Principal Investigator(s)/ Project Leader(s)
SCRIPPS RESEARCH INSTITUTE, THE 2017 NIAID
NIAID
$962,498
View Similar Projects
https://reporter.nih.gov/search/cPyQvwQjdkGuV5EFS2vNmw/projects
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM